Mexico Pharmaceutical Cro Market Size & Outlook, 2026-2033

The pharmaceutical cro market in Mexico is expected to reach a projected revenue of US$ 1,412.9 million by 2033. A compound annual growth rate of 8.6% is expected of Mexico pharmaceutical cro market from 2026 to 2033.
Revenue, 2025 (US$M)
$735.6
Forecast, 2033 (US$M)
$1,412.9
CAGR, 2026 - 2033
8.6%
Report Coverage
Mexico

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Mexico pharmaceutical cro market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Mexico pharmaceutical cro market highlights

  • The Mexico pharmaceutical cro market generated a revenue of USD 735.6 million in 2025 and is expected to reach USD 1,412.9 million by 2033.
  • The Mexico market is expected to grow at a CAGR of 8.6% from 2026 to 2033.
  • In terms of segment, clinical was the largest revenue generating type in 2025.
  • Pre-Clinical is the most lucrative type segment registering the fastest growth during the forecast period.


Pharmaceutical cro market data book summary

Market revenue in 2025USD 735.6 million
Market revenue in 2033USD 1,412.9 million
Growth rate8.6% (CAGR from 2026 to 2033)
Largest segmentClinical
Fastest growing segmentPre-Clinical
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationDrug Discovery, Pre-Clinical, Clinical
Key market players worldwidePAREXEL, Icon PLC, Thermo Fisher Scientific Inc, Medpace Holdings Inc, IQVIA Holdings Inc, CTI Clinical Trial and Consulting Services, Wuxi AppTec Co Ltd


Other key industry trends

  • In terms of revenue, Mexico accounted for 1.6% of the global pharmaceutical cro market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In North America, U.S. pharmaceutical cro market is projected to lead the regional market in terms of revenue in 2033.
  • Mexico is the fastest growing regional market in North America and is projected to reach USD 1,412.9 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Pharmaceutical CRO Market Companies

Name Profile # Employees HQ Website
CTI Clinical Trial and Consulting Services View profile 501-1000 Covington, Kentucky, United States, North America http://ctifacts.com
PAREXEL View profile 10001+ Waltham, Massachusetts, United States, North America http://www.parexel.com
IQVIA Holdings Inc View profile 87000 2400 Ellis Road, Durham, NC, United States, 27703 https://www.iqvia.com
Medpace Holdings Inc View profile 5800 5375 Medpace Way, Cincinnati, OH, United States, 45227 https://www.medpace.com
Wuxi AppTec Co Ltd View profile 41116 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 https://www.wuxiapptec.com
Icon PLC View profile 41150 South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 https://www.iconplc.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com

Mexico Drug Discovery - Pharmaceutical Cro Market, 2025 - 2033 (US$M)

Mexico Pharmaceutical CRO Market Outlook Share, 2025 & 2033 (US$M)

Mexico Drug Discovery - Pharmaceutical Cro Market, 2025 - 2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online